These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 37834765)
1. An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome. Dumesic DA; Abbott DH; Chazenbalk GD J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834765 [TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation. Dumesic DA; Padmanabhan V; Chazenbalk GD; Abbott DH Reprod Biol Endocrinol; 2022 Jan; 20(1):12. PubMed ID: 35012577 [TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming. Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780 [TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome. Dumesic DA; Winnett C; Lu G; Grogan TR; Abbott DH; Naik R; Chazenbalk GD Fertil Steril; 2023 Jan; 119(1):116-126. PubMed ID: 36400597 [TBL] [Abstract][Full Text] [Related]
8. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. Condorelli RA; Calogero AE; Di Mauro M; Mongioi' LM; Cannarella R; Rosta G; La Vignera S J Endocrinol Invest; 2018 Apr; 41(4):383-388. PubMed ID: 28942551 [TBL] [Abstract][Full Text] [Related]
9. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633 [TBL] [Abstract][Full Text] [Related]
10. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965 [TBL] [Abstract][Full Text] [Related]
11. Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome. Fisch SC; Nikou AF; Wright EA; Phan JD; Leung KL; Grogan TR; Abbott DH; Chazenbalk GD; Dumesic DA Fertil Steril; 2018 Dec; 110(7):1367-1376. PubMed ID: 30503136 [TBL] [Abstract][Full Text] [Related]
12. Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health. Brennan KM; Kroener LL; Chazenbalk GD; Dumesic DA Obstet Gynecol Surv; 2019 Apr; 74(4):223-231. PubMed ID: 31344250 [TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities. Elkind-Hirsch KE Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059 [TBL] [Abstract][Full Text] [Related]
15. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome. Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322 [TBL] [Abstract][Full Text] [Related]
17. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome. de Medeiros SF; Rodgers RJ; Norman RJ Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457 [TBL] [Abstract][Full Text] [Related]
18. Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women. Dumesic DA; Tulberg A; McNamara M; Grogan TR; Abbott DH; Naik R; Lu G; Chazenbalk GD J Endocr Soc; 2021 Nov; 5(11):bvab158. PubMed ID: 34661039 [TBL] [Abstract][Full Text] [Related]
19. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728 [TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]